Taste and Smell Impairment in COVID‐19: An AAO‐HNS Anosmia Reporting Tool‐Based Comparative Study
Authors:
Open Access
- 9 June 2020
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 163 (3) , 473-479
Abstract
Objective: To identify the taste and smell impairment in coronavirus disease 2019 (COVID‐19)–positive subjects and compare the findings with COVID‐19–negative subjects using the American Academy of Otolaryngology–Head and Neck Surgery (AAO‐HNS) Anosmia Reporting Tool.Setting: Tertiary referral center/COVID‐19 pandemic hospital.Study Design: Comparative study.Subjects and Methods: After power analysis, 128 subjects were divided into 2 groups according to real‐time polymerase chain reaction (RT‐PCR) COVID‐19 testing results. Subjects were called via telephone, and the AAO‐HNS Anosmia Reporting Tool was used to collect responses.Results: The mean age of the study group was 38.63 ± 10.08 years. At the time of sampling, rhinorrhea was significantly high in the COVID‐19–negative group, whereas those complaints described as “other” were significantly high in the COVID‐19–positive group. There was a significant difference in the smell/taste impairment rates of the groups (n = 46% [71.9%] for the COVID‐19–positive group vs n = 17 [26.6%] for the COVID‐19–negative group, P =. 001). For subjects with a smell impairment, anosmia rates did not differ between the groups. The rates of hyposmia and parosmia were significantly high in the COVID‐19–positive group. For the subjects with taste impairment, ageusia rates did not differ between groups. The rate of hypogeusia and dysgeusia was significantly high in the COVID‐19–positive group. Logistic regression analysis indicates that smell/taste impairment in COVID‐19–positive subjects increases the odds ratio by 6.956 (95% CI, 3.16‐15.29) times.Conclusion: COVID‐19–positive subjects are strongly associated with smell/taste impairment.Keywords
This publication has 13 references indexed in Scilit:
- Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptomsInternational Forum of Allergy & Rhinology, 2020
- Presentation of New Onset Anosmia During the COVID-19 PandemicRhinology journal, 2020
- Anosmia and Ageusia: Common Findings in COVID‐19 PatientsThe Laryngoscope, 2020
- Otolaryngology Providers Must Be Alert for Patients with Mild and Asymptomatic COVID‐19Otolaryngology–Head and Neck Surgery, 2020
- Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European studyEuropean Archives of Oto-Rhino-Laryngology, 2020
- Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statementAllergy, 2020
- Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmiabioRxiv, 2020
- Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional StudyClinical Infectious Diseases, 2020
- Olfactory Disorders following Upper Respiratory Tract Infections2006
- Postviral olfactory lossOtolaryngologic Clinics of North America, 2004